Biotest AG
OTC:BIESF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biotest AG
OTC:BIESF
|
DE |
|
IAC Inc
F:4LRA
|
US |
|
A
|
Atlantic Sapphire ASA
XMUN:4AS
|
NO |
|
Liontown Resources Ltd
ASX:LTR
|
AU |
|
Healthia Ltd
F:HE3
|
AU |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BIESF's stock price target?
Not Available
BIESF does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Biotest AG?
Projected CAGR
-1%
Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 1 year is -1%.
What is the Operating Income forecast for Biotest AG?
Projected CAGR
25%
Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 1 year is 25%.